As the president and executive director of LabCentral, a shared laboratory space for biotech and life-sciences startups, Fruehauf is responsible for all aspects of LabCentral’s operation. A physician and successful biotech entrepreneur, Fruehauf founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. He is also a co-founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits. Fruehauf earned his medical degree at the University of Frankfurt and his Ph.D. at the University of Heidelberg.